Literature DB >> 11114260

p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis.

L J Martin1.   

Abstract

Motor neuron degeneration in amyotrophic lateral sclerosis (ALS) is a form of apoptosis, but the mechanisms for this neuronal cell death are not known. We evaluated whether motor neuron degeneration in ALS is associated with changes in the levels and function of the apoptosis regulating protein p53. The protein levels and localizations of p53 are abnormal in ALS. By immunoblotting, p53 is elevated in the nuclear compartment of selectively vulnerable CNS regions in individuals with ALS compared to age-matched controls. The levels of a carboxyl-terminal degradation fragment of p53 were decreased in cases of ALS. DNA binding assay demonstrated that the increased p53 in individuals with ALS had competent DNA binding activity. Immunocytochemistry revealed that in normal human CNS p53 is expressed in subsets of nonneuronal cells, but it is found only rarely in neurons; in contrast, in individuals with ALS, p53 is frequently found in motor neurons of spinal cord and motor cortex and is upregulated in astroglia. It is concluded that p53 may participate in the mechanisms for motor neuron apoptosis in ALS. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114260     DOI: 10.1006/nbdi.2000.0314

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  DNA damage profiling in motor neurons: a single-cell analysis by comet assay.

Authors:  Lee J Martin; Zhiping Liu
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 3.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 4.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

Review 5.  DNA damage and repair: relevance to mechanisms of neurodegeneration.

Authors:  Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

6.  Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.

Authors:  M A Lim; M A Selak; Z Xiang; D Krainc; R L Neve; B C Kraemer; J L Watts; R G Kalb
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

7.  DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.

Authors:  Arif Y Shaikh; Lee J Martin
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 8.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

10.  Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex.

Authors:  Lee J Martin; Zhiping Liu; Jacqueline Pipino; Barry Chestnut; Melissa A Landek
Journal:  Cereb Cortex       Date:  2008-09-26       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.